ML15274A539

Shine Medical Technologies, Inc., Application for Construction Permit, Description of Process for Preparing Consolidated Liquid Waste Streams for Disposal as Class a Waste

ML15274A539
Person / Time
Site:	SHINE Medical Technologies
Issue date:	10/01/2015
From:	Piefer G SHINE Medical Technologies
To:	Document Control Desk, Office of Nuclear Reactor Regulation
References
SMT-2015-056
Download: ML15274A539 (2)

Text

October 1, 2015 U.S. Nuclear Regulatory Commission ATT N: Document Control Desk Wa shington, DC 20555 SMT-2015-056 10 CFR 50.30

References:

(1) SHINE Medical Technologies, Inc. letter to NRC, dated March 26, 2013, Part One of the SHINE Medical Technologies, Inc. Application for Construction Permit (ML 130880226)

(2) SHINE Medical Technologies, Inc. letter to NRC, dated May 31, 2013, Part Two of the SHINE Medical Technologies, Inc. Application for Construction Permit (ML 13172A361)

SHINE Medical Technologies, Inc. Application for Construction Permit Description of the SHINE Process for Preparing Consolidated Liquid Waste Streams for Disposal as Class A Waste Pursuant to 10 CFR 50.30, SHINE Medical Technologies, Inc. (SHINE) submitted an application for a construction permit to construct a medical isotope facility to be located in Janesville, WI (References 1 and 2). SHINE determined that additional clarifying information could be provided, describing the SHINE process for preparing consolidated liquid waste streams for disposal as Class A waste at EnergySolutions.

Enclosure 1 provides a description of the SHINE process for preparing consolidated liquid waste streams for disposal as Class A waste. If you have any questions, please contact Mr. Jim Costedio, Licensing Manager, at 608/210-1730.

I declare under the penalty of perjury that the foregoing is true and correct. Executed on October 1, 2015. Very truly yours, Gregory Piefer, Ph.D. Chief Executive Officer SHINE Medical Technologies, Inc. Docket No. 50-608 Enclosure cc: Administrator, Region Ill, USNRC Project Manager, USNRC Environmental Project Manager, USNRC Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health 2555 Industrial Drive I Monona, WI 53713 I P (608) 210* 1060 I F (608) 210-2504 I www.shinemed.com Page 1 of 1 ENCLOSURE 1 SHINE MEDICAL TECHNOLOGIES, INC.

SHINE MEDICAL TECHNOLOGIES, INC. APPLICATION FOR CONSTRUCTION PERMIT DESCRIPTION OF THE SHINE PROCESS FOR PREPARING CONSOLIDATED LIQUID WASTE STREAMS FOR DISPOSAL AS CLASS A WASTE Consolidated waste streams at the SHINE facility consist of spent washes, rotary evaporate condensate, uranium extraction (UREX) raffinate, scrubber solution, decontamination waste, and spent eluate solution.

The UREX raffinate waste stream is Class B as generated, and is sent to the radioactive liquid waste tank, where it is consolidated with the other liquid waste streams described above. The consolidated waste stream is held-up for decay in the radioactive liquid waste tank , then processed and solidifi ed.

Following solidification, the waste is temporarily stored on site for decay in the Waste Staging and Shipping Building in order to meet both Department of Transportation (DOT) and Class A waste limits

.

SHINE expects that the combination of the processes described above will lead to a final waste classification of Class A for the solidified aqueous waste stream, and will therefore be amenable for disposal as Class A waste at EnergySolutions

.